Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03911154 · ClinicalTrials.gov registry record · NA
Evaluation of SmartSleep Technology for Improving the Efficiency and Restorative Quality of Sleep in Healthy Adults
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT03911154: Completed NA study, sponsored by University of Pennsylvania.
NCT03911154 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03911154, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
This study aims to assess whether slow wave sleep enhancement using SmartSleep technology benefits daytime cognitive performance during periods of chronic sleep restriction.
Interventions
- DEVICE Philips SmartSleep Technology--Continuous Fixed Interval modality
- DEVICE Philips SmartSleep Technology--Block modality
- DEVICE Philips SmartSleep Technology--In-Phase Adjustable modality
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2019-04-29 |
| Est. Completion | 2021-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03911154
The ClinicalTrials.gov registry entry for NCT03911154 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Philips SmartSleep Technology--Continuous Fixed Interval modality is the first listed.
NCT03911154 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03911154 about?
NCT03911154 is a clinical study titled "Evaluation of SmartSleep Technology for Improving the Efficiency and Restorative Quality of Sleep in Healthy Adults". This study aims to assess whether slow wave sleep enhancement using SmartSleep technology benefits daytime cognitive performance during periods of chronic sleep restriction.
What is the current status of trial NCT03911154?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2019-04-29. Estimated completion is 2021-06-30.
What interventions are being tested in trial NCT03911154?
The interventions under investigation include: Philips SmartSleep Technology--Continuous Fixed Interval modality (DEVICE), Philips SmartSleep Technology--Block modality (DEVICE), Philips SmartSleep Technology--In-Phase Adjustable modality (DEVICE).
Who is sponsoring clinical trial NCT03911154?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.